Converging evidence suggests a central role for dysfunction of the subgenual anterior cingulate cortex (sgACC) in the pathophysiology of major depressive disorder (MDD). Underlying mechanisms may include altered GABAergic function. Expression of somatostatin (SST), an inhibitory neuropeptide localized to a subset of GABA neurons, has been shown to be lower in the dorsolateral prefrontal cortex of male MDD subjects. Here, to investigate whether alterations in SST may contribute to sgACC dysfunction in MDD, and whether the alterations display sex-specificity, we measured sgACC SST at the mRNA and precursor peptide levels in a large cohort of subjects with MDD. SST mRNA levels were analyzed by quantitative PCR (qPCR) in the postmortem sgACC from male (n = 26) and female (n = 25) subjects with MDD and sex-matched subjects with no psychiatric diagnosis (n = 51). Prepro-SST protein levels were assessed in a subset of subjects (n = 42 pairs) by semi-quantitative Western blot. The mRNA expression of SST was significantly reduced by 38% in female subjects and by 27% in male subjects with MDD. The characteristic age-related decline in SST expression was observed in control (Pearson R = − 0.357, p = 0.005) but not MDD (R = − 0.104, p = 0.234) subjects, as low expression was detected across ages in MDD subjects. Protein expression was similarly reduced by 19% in both MDD groups, and findings were more robust in female (p = 0.0056) than in males (p = 0.0373) compared to respective controls. In conclusion, low SST represents a robust pathological finding in MDD. Specifically, alterations in SST signaling and/or SST-bearing GABA neurons may represent a critical pathophysiological entity that contributes to sgACC dysfunction and that matches to the high female vulnerability to develop MDD.
Introduction
An extended corticolimbic circuitry regulating mood has been implicated in the pathophysiology and treatment of MDD (Seminowicz et al., 2004) . One of the components of this circuitry, the sgACC has been shown to play a major role in both the induction of the depressive state and in treatment response to multiple modalities (Agid et al., 2007) . For example, positive response from a baseline depressed state, regardless of treatment modality (electroconvulsive therapy, deep brain stimulation, and antidepressants or placebo) is associated with a decrease in sgACC activity (George et al., 1999; Mayberg et al., 1999; Nobler et al., 2001; Mayberg, 2002) . Furthermore, with tryptophan depletion or recollection of a sad memory, transient increase in sgACC activity occurs in healthy non-depressed subjects (Mayberg et al., 1999; Talbot and Cooper, 2006) .
Increasing evidence suggests an impaired excitation/inhibition balance in MDD potentially mediated by decreased GABA content, as observed by proton magnetic spectroscopy in occipital and frontal cortices (Sanacora et al., 1999 (Sanacora et al., , 2004 , or by transcranial magnetic stimulation paradigms (Levinson et al., 2010) , which is reversed after antidepressant treatments (Sanacora et al., 2002 (Sanacora et al., , 2003 . As GABA synthesis and release is found largely in inhibitory neurons, these results suggest that altered GABA neuronal microcircuitry and associated inhibition may contribute to altered sgACC function in MDD (Valentine and Sanacora, 2009 ). Dysregulation of the neuronal/ interneuronal microcircuitry within the sgACC has yet to be elucidated. Morphometric studies have reported reduced density and size of cortical neurons (Brodmann transitional area 10-47, 47) (Rajkowska et al., 1999) , recently attributed to interneurons in some studies (Brodmann area 9, 17, and 47), but not all (Brodmann Area 24) (Rajkowska et al., 2007; Maciag et al., 2010) . The nature of the affected cells in MDD is beginning to be characterized, using cellular markers expressed in distinct interneuronal populations. Accordingly, the density of calbindin-immunoreactive (CB) interneurons was significantly reduced in occipital and orbitofrontal cortices of MDD subjects (Rajkowska et al., 2007; Maciag et al., 2010) , but unchanged in two other studies in cingulate and dorsolateral prefrontal cortex (Beasley et al., 2002; Cotter et al., 2002) . In the context of a survey of markers for GABA neuron populations, we recently identified a
